Health benefits of honey: Implications for treating cardiovascular diseases

Current Nutrition and Food Science

Volumn 7, Issue 4, 2011, Pages 232-252

  Farooqui, Tahira ^a   Farooqui, Akhlaq A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Anti inflammatory; Antibacterial; Antioxidant; Cardiovascular diseases; Flavonoids; Honey; Polyphenols; Reactive oxygen species

Indexed keywords

ACACETIN; ACID PHOSPHATASE; ALPHA GLUCOSIDASE; AMINO ACID; AMYLASE; APIGENIN; ASCORBIC ACID; BETA AMYLASE; CARBOHYDRATE; CATALASE; CHROMIUM; ENZYME; FLAVONOID; FRUCTOSE; GLUCOSE; GLUCOSE OXIDASE; HESPERETIN; MAGNESIUM; MONOSACCHARIDE; NARINGENIN; NICOTINIC ACID; PANTOTHENIC ACID; PINOCEMBRINE; POLYPHENOL; POTASSIUM; PYRIDOXINE; RIBOFLAVIN; SELENIUM; THIAMINE; UNINDEXED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CHEMICAL COMPOSITION; DRUG MECHANISM; HEART PROTECTION; HONEY; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THERAPY EFFECT; TRADITIONAL MEDICINE;

EID: 84858318981     PISSN: 15734013     EISSN: 22123881     Source Type: Journal    
DOI: 10.2174/157340111804586448     Document Type: Article

References (192)

1. Crane E. The Archaeology of Beekeeping. London: Gerald Duckworth & Co., 1983.
2. Prescott L, Harley JP, Klein DA. Microbiology. Boston: WCB/McGraw-Hill., 1999.
3. Bang LM, Buntting C, Molan P. The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing. J Altern Complement Med 2003; 9: 267-73.
4. White JW, Subers MH, Schepartz AI. The identification of inhibine, the antibacterial factor in honey, as hydrogen peroxide and its origin in a honey glucose-oxidase system. Biochim Biophys Acta 1963; 73: 57-70.
5. USDA. 1962. White JW Jr., et al. Composition of American Honeys. Tech. Bull. 1261. Agricultural Research Service, USDA, Washington, DC.
6. White JW Jr. Detection of honey adulteration by carbohydrate analysis. JAOAC 1980; 63: 11-8.
7. Ball DW. The chemical composition of honey. J Chem Educ 2007; 84: 1643-6.
8. Molan PC, Smith IM, Reid GM. A comparison of the antibacterial activity of some New Zealand honeys. J Apic Res 1988; 27: 252-6.
9. Allen KL, Molan PC, Reid GM. A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 1991; 43: 817-22.
10. Brady N, Molan P, Bang L. A survey of non-manuka New Zealand honeys for antibacterial and antifungal activities. J Apic Res 2004; 43: 47-52.
11. Irish J, Blair S, Carter DA. The antibacterial activity of honey derived from Australian flora. PLoS One 2011; 6: e18229.
12. Ohashi K, Natori S, Kubo T. Expression of amylase and glucose oxidase in the hypopharyngeal gland with an age-dependent role change of the worker honeybee (Apis mellifera L.). Eur J Biochem 1999; 265: 127-33.
13. Janmaat AF, Winston ML, Ydenberg RC. Condition-dependent response to changes in pollen stores by honey bee (Apis mellifera) colonies with different parasitic loads. Behav Ecol Sociobiol 2000; 47: 171-9.
14. Yang X, Cox-Foster DL. Impact of an ectoparasite on the immunity and pathology of an invertebrate: evidence for host immunosuppression and viral amplification. Proc Natl Acad Sci USA 2005; 102: 7470-5.
15. Mattila HR, Otis GW. Effects of pollen availability and Nosema infection during the spring on division of labor and survival of worker honey bees (Hymenoptera: Apidae). Environ Entomol 2006; 35: 708-17.
16. Bankova VS, DcCastro SL, Marucci MC. Propolis recent advances in chemistry and plant origin. Apidologic 2000; 31: 3-15.
17. Castalado S, Capasso F: Propolis, an old remedy used in modern medicine. Fitoterapia 2002; 73(Suppl 1): S1-6.
18. Orsatti CL, Missima F, Pagliarone AC, et al. Propolis immunomodulatory action in vivo on Toll-like receptors 2 and 4 expression and on pro-inflammatory cytokines production in mice. Phytother Res 2010; 24: 1141-6.
19. Farooqui T, Farooqui AA. Molecular mechanism underlying the therapeutic activities of propolis: a critical review. Curr Nutr Food Sci 2010; 6: 186-99.
20. Farooqui T, Farooqui AA. Beneficial effects of propolis on human Health: pharmacological and molecular aspects. In: "Phytochemicals and Human Health: Pharmacological and Molecular Aspects", (Farooqui AA. And Farooqui T. eds), Nova Science Publishers, Hauppage, New York, 2011, 219-39.
21. Farooqui T, Farooqui AA. Beneficial effects of propolis on human health and neurological diseases. Frontiers Biosci 2012; E4: 779-93.
22. Alyane M, Kebsa LB, Boussenane HN, Rouibah H, Lahouel M. Cardioprotective effects and mechanism of action of polyphenols extracted from propolis against doxorubicin toxicity. Pak J Pharm Sci 2008; 21: 201-9.
23. Khalil ML, Sulaiman SA. The potential role of honey and its polyphenols in preventing heart disease: a review. Afr J Tradit Comlement Altern Med 2010; 7: 315-21.
24. Yaghoobi N, Al-Waili N, Ghayour-Mobarhan M, et al. Natural honey and cardiovascular risk factors; effects on blood glucose, cholesterol, triacylglycerole, CRP, and body weight compared with sucrose. Sci World J 2008; 8: 463-9.
25. Cai H, Harrison G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-4.
26. Tousoulis D, Briasoulis A, Papageorgiou N, et al. Oxidative stress and endothelial function: therapeutic interventions. Recent Pat Cardiovasc Drug Discov 2011; 6: 103-14.
27. Griendling KK, Sorescu D, Ushio-Fukai. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
28. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010; 459: 923-39.
29. Jeffrey AE, Echazarreta CM. Medical uses of honey. Rev Biomed 1996; 7: 43-9.
30. Bogdanov S. Nutritional and functional properties of honey. Vopr Pitan 2010; 79: 4-13.
31. Doner LW. The sugars of honey-a review. J Sci Food Agric 1977; 28: 443-56.
32. Siddiqui IR. The sugars of honey. Adv Carbohyd Chem 1970; 25: 285-309.
33. Bogdanov S, Jurendic T, Sieber R, Gallmann P. Honey for nutrition and health: a review. J Am Coll Nutr 2008; 27: 677-89.
34. Vorlova L, Přidal A. Invertase and diastase activity in honeys of Czech provenience. Acta univ agric et silvic Mendel Brun L, 2002; 5; 57-66.
35. Sánchez MP, Huidobro JF, Mato I, Muniategui S, Sancho MT. Evolution of invertase activity in honey over two years. J Agric Food Chem 2001; 49: 416-22.
36. Schepartz AI, Subers MH. Catalase in honey. J Apic Res 1966; 5: 37-43.
37. Babacan S, Rand AG. Purification of amylase from honey. J Food Sci 2005; 70: C413-8.
38. Babacan S, Rand AG. Characterization of honey amylase. J Food Sci 2007; 72: C050-5.
39. Ohashi K, Natori S, Kubo T. Expression of amylase and glucose oxidase in the hypopharyngeal gland with an age-dependent role change of the worker honeybee (Apis mellifera L.). Eur J Biochem 1999; 265: 127-33.
40. Shepartz AI, Subers MH. The glucose oxidase of honey I. Purification and some general properties of the enzyme. Biochimica et Biophysica Acta (BBA)-Specialized Section on Enzymological Subjects 1964; 85: 228-37.
41. Huidobro JF, Sánchez MP, Muniategui S, Sancho MT. Catalase in honey. J AOAC Int 2005; 88: 800-4.
42. Alonso-Torre SR, Cavia MM, Fernández-Muiño MA, Moreno G, Huidobro JF, Sancho MT. Evolution of acid phosphatase activity of honeys from different climates. Food Chem 2006; 97: 750-5.
43. Mato I, Huidobro JF, Simal-Lozano J, Sancho MT. Significance of nonaromatic organic acids in honey. J Food Prot 2003; 66: 2371-6.
44. Mato I, Huidobro JF, Simal-Lozano J, Sancho MT. Rapid determination of nonaromatic organic acids in honey by capillary zone electrophoresis with direct ultraviolet detection. J Agric Food Chem 2006; 54: 1541-50.
45. Bogdanov S, Haldimann M, Luginbühl W, Gallmann P. Minerals in honey: environmental, geographical and botanical aspects. J Api Res 2007; 46: 269-75.
46. León-Ruiz V, Vera S, González-Porto AV, San Andrés MP. Vitamin C and sugar levels as simple markers for discriminating Spanish honey sources. J Food Sci 2011; 76: C356-61.
47. Ciulu M, Solinas S, Floris I, Panzanelli A, Pilo MI, Piu PC, Spano N, Sanna G. RP-HPLC determination of water-soluble vitamins in honey. Talanta 2011; 83: 924-9.
48. Alvarez-Suarez JM, Tulipani S, Díaz D, et al. Antioxidant and antimicrobial capacity of several monofloral Cuban honeys and their correlation with color, polyphenol content and other chemical compounds. Food Chem Toxicol 2010; 48: 2490-9.
49. Amiot MJ, Aubert S, Gonnet M, Tacchni M. Phenolic composition of honeys:preliminary study on identification and group quantification. Apidologie 1989; 20: 115-25.
50. Bogdanov S. Nutritional and functional properties of honey. Vopr Pitan 2010; 79: 4-13.
51. Stawiarz E, Wrólewska A. Melissopalynological analysis of multifloral honeys from the Sandomierska upland area of Poland. J Apiculture Sci 2010; 54: 65-75.
52. Tomás-Barberán FA, Martos I, Ferreres FI, Radovic BS, Anklam E. HPLC flavonoid profiles as markers for the botanical origin of European unifloral honeys. J Sci Food Agric 2001; 81: 485-96.
53. Martos I, Ferreres F, Yao L, D'Arcy B, Caffin N, Tomás-Barberán FA. Flavonoids in monospecific eucalyptus honeys from Australia. J Agric Food Chem 2000; 48: 4744-8.
54. Petrus K, Schwartz H, Sontag G. Analysis of flavonoids in honey by HPLC coupled with coulometric electrode array detection and electrospray ionization mass spectrometry. Anal Bioanal Chem 2011; 400: 2555-63.
55. Ferreres F, Giner JM, Tomás-Barberán FA. A comparative study of hesperetin and methyl anthranilate as markers of the floral origin of citrus honey. J Sci Food Agric 1994; 65: 371-2.
56. Ferreres F, Andrade P, Tomás-Barberán FA. Natural occurrence of abscisic acid in heather honey and floral nectar. J Agric Food Chem 1996; 44: 2053-6.
57. Ferreres F, Juan T, Perez-Arquillue C, Herrera-Marteache A, Garcia-Viguera C, Tomás-Barberán FA. Evaluation of pollen as a source of kaempferol in rosemary honey. J Sci Food Agric 1998; 77: 506-10.
58. Hamdy AA, Ismail HM, Al-Ahwal Ael-M, Gomaa NF. Determination of flavonoid and phenolic Acid contents of clover, cotton and citrus floral honeys. J Egypt Public Health Assoc 2009; 84: 245-59.
59. Gómez-Caravaca AM, Gómez-Romero M, Arráez-Román D, Segura-Carretero A, Fernández-Gutiérrez A. Advances in the analysis of phenolic compounds in products derived from bees. J Pharm Biomed Anal 2006; 41: 1220-34.
60. Wang J, Li QX. Chemical composition, characterization, and differentiation of honey botanical and geographical origins. Adv Food Nutr Res 2011; 62: 89-137.
61. Popova M, Bankova V, Butovska D, et al. Validated methods for the quantification of biologically active constituents of poplar-type propolis. Phytochem Anal 2004; 15: 235-40.
62. Medić-Sarić M, Rastija V, Bojić M, Maleš Ž. From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. Nutr J 2009; 8: 33.
63. Jaganathi IB, Crozier A. Dietary flavonoids and phenolic compounds. In: Fraga CG, Ed. Plant phenolics and human health: biochemistry, nutrition, and pharmacology. John Wiley & Sons, Inc. 2010; pp. 1-50.
64. Harborne JB, Mabry TJ, Mabry H. The Flavonoids, London, Chapman and Hall, 1974.
65. Beecher GR. Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 2003; 133: 3248S-54S.
66. Omotayo EO, Gurtu S, Sulaiman SA, Ab Wahab MS, Sirajuddin KN, Salleh MS. Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res 2010; 80: 74-82.
67. Alvarez-Suarez JM, Tulipani S, Díaz D, et al. Antioxidant and antimicrobial capacity of several monofloral Cuban honeys and their correlation with color, polyphenol content and other chemical compounds. Food Chem Toxicol 2010; 48: 2490-9.
68. Rakha MK, Nabil ZI, Hussein AA. Cardioactive and vasoactive effects of natural wild honey against cardiac malperformance induced by hyperadrenergic activity. J Med Food 2008; 11: 91-8.
69. Viuda-Martos M, Ruiz-Navajas Y, Fernández-López J, Pérez-Alvarez JA. Functional properties of honey, propolis, and royal jelly. Food Sci 2008; 73: R117-R24.
70. Estevinho L, Pereira AP, Moreira L, Dias LG, Pereira E. Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol 2008; 46: 3774-9.
71. Khan MS, Devaraj H, Devaraj N. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamineinduced preneoplastic nodules in rats. Toxicol Appl Pharmacol 2011; 251: 85-94.
72. Khalil MI, Sulaiman SA, Boukraa L. Antioxidant properties of honey and its role in preventing health disorder. The Open Nutraceuticals 2010; J 3: 6-16.
73. Lotito SB, Frei B. Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. J Biol Chem 2006; 281: 37102-10.
74. Takano-Ishikawa Y, Goto M, Yamaki K. Structure-activity relations of inhibitory effects of various flavonoids on lipopolysaccharide-induced prostaglandin E2 production in rat peritoneal macrophages: comparison between subclasses of flavonoids. Phytomedicine 2006; 13: 310-7.
75. Ahn MR, Kunimasa K, Kumazawa S, et al. Correlation between antiangiogenic activity and antioxidant activity of various components from propolis. Mol Nutr Food Res 2009; 53: 643-51.
76. Kumazawa S, Hamasaka T, Nakayama T. Antioxidant activity of propolis of various geographic origins. Food Chem 2004; 84: 329-39.
77. van Acker SA, van Den Berg DJ, Tromp MN, et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 1996; 20: 331-42.
78. Jovanovic SV, Steenken S, Tosic M, Marjanovic B, Simic MG. Flavonoids as antioxidants. J Am Chem Soc 1994; 116: 4846-51.
79. Bors W, Heller W, Michel C, Saran M. In: Packer L, Glazer AN, Eds. Methods in Enzymology; Academic Press: San Diego, CA, 1990; Vol. 186, pp. 343-55.
80. Amić D, Davidovic-Amić D, Baselo D, Rastija V, Lucić B, Trinajstić N. SAR and QSAR of the antioxidant activity of flavonoids. Curr Med Chem 2007; 14: 827-45.
81. Kumazawa S, Ueda R, Hamasaka T, Fukumoto S, Fujimoto T, Nakayama T. Antioxidant prenylated flavonoids from propolis collected in Okinawa, Japan. J Agric Food Chem 2007; 55: 7722-5.
82. Abuharfeil N, Al-Oran R, Abo-Shehada M. The effect of bee honey on the proliferative activity of human B-and T-lymphocytes and the activity of phagocytes. Food Agric Immun 199; 11: 169-77.
83. Al-Waili NS, Haq A. Effect of honey on antibody production against thymus-dependent and thymus-independent antigens in primary and secondary immune responses. J Med Food 2004; 7: 491-4.
84. Tonks AJ, Dudley E, Porter NG, Parton J, Brazier J, Smith EL, Tonks A. A 5.8-kDa component of manuka honey stimulates immune cells via TLR4. J Leukoc Biol 2007; 82: 1147-55.
85. Jones KP. The role of honey in wound healing and repair. In: Munn P, Jones R, eds. Honey and Healing. IBRA, Cardiff, UK. 2000.
86. Tonks A, Cooper RA, Price AJ, Molan PC, Jones KP. Stimulation of TNF-alpha release in monocytes by honey. Cytokine 2001; 14: 240-2.
87. Tonks AJ, Cooper RA, Jones KP, Blair S, Parton J, Tonks A. Honey stimulates inflammatory cytokine production from monocytes. Cytokine 2003; 21: 242-7.
88. Timm M, Bartelt S, Hansen EW. Immunomodulatory effects of honey cannot be distinguished from endotoxin. Cytokine 2008; 42: 113-20.
89. Lyu SY, Park WB. Production of cytokine and NO by RAW 264.7 macrophages and PBMC in vitro incubation with flavonoids. Arch Pharm Res 2005; 28: 573-81.
90. Hendriks JJ, Alblas J, Pol SM van der, van Tol EA, Dijkstra CD, de Vries HE. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med Sci 2004; 200: 1667-72.
91. Comalada M, Ballester I, Bailon E, Sierra S, Xaus J, Galvez J. Inhibition of pro-inflammatory markers in primary bone marrow derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem Pharmacol 2006; 72: 1010-21.
92. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 2001; 296: 181-7.
93. Huang YT, Hwang JJ, Lee PP, Ke FC, Huang JH, Huang CJ. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 1999; 128: 999-1010.
94. Spencer JP, Kuhnle GG, Williams RJ. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 2003; 372(Pt 1): 173-81.
95. Wilkinson JM, Cavanagh HM. Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa. J Med Food 2005; 8: 100-3.
96. Molan PC. Re-introducing honey in the management of wounds and ulcers-theory and practice. Ostomy Wound Manage. 2002; 48: 28-40.
97. Eddy JJ, Gideonsen MD, Mack GP. Practical considerations of using topical honey for neuropathic diabetic foot ulcers: a review. WMJ 2008; 107: 187-190.
98. Makhdoom A, Khan MS, Lagahari MA, Rahopoto MQ, Tahir SM, Siddiqui KA. Management of diabetic foot by natural honey. J Ayub Med Coll Abbottabad 2009; 21: 103-5.
99. Tsuchiya H, Sato M, Miyazaki T, et al. Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 1996; 50: 27-34.
100. Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Ag 2005; 26: 343-56.
101. Halbwirth H. The creation and physiological relevance of divergent hydroxylation patterns in the flavonoid pathway. Int J Mol Sci 2010; 11: 595-621.
102. Brady NF, Molan PC, Harfoot CG. The sensitivity of dermatophytes to the antimicrobial activity of manuka honey and other honey. Pharm Sci 1997; 2: 1-3.
103. Afolayan AJ, Meyer JJ. The antimicrobial activity of 3,5,7-trihydroxyflavone isolated from the shoots of Helichrysum aureonitens. J Ethnopharmacol 1997; 57: 177-81.
104. Critchfield JW, Butera ST, Folks TM. Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res Hum Retroviruses 1996; 12: 39-46.
105. Hu CQ, Chen K, Shi Q, Kilkuskie RE, Cheng YC, Lee KH. Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids. J Nat Prod 1994; 57: 42-51.
106. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-73.
107. Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G. Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag 2011; 7: 475-82.
108. Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 2008; 117: 3031-8.
109. Standridge JB. Hypertension and atherosclerosis: clinical implications from the ALLHAT trial. Curr Atheroscler Rep 2005; 7: 132-9.
110. Peiro C, Lafuente N, Matesanz N, et al. High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br J Pharmacol 2001; 133: 967-74.
111. Kim CS, Kim YR, Naqvi A, et al. Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc. Cardiovasc Res 2011; 92: 466-75.
112. Liu CF, Qin L, Ren JY, et al. Elevated plasma lipoproteinassociated phospholipase A2 activity is associated with plaque rupture in patients with coronary artery disease. Chin Med J (Engl) 2011; 124: 2469-73.
113. Zhang YC, Wei JJ, Wang F, Chen MT, Zhang MZ. Elevated levels of oxidized low-density lipoprotein correlate positively with Creactive protein in patients with acute coronary syndrome. Cell Biochem Biophys 2011, In press.
114. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol 2009; 196: 193-222.
115. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-6.
116. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
117. Li JJ, Chen JL. Inflammation may be a bridge connecting hypertension and atherosclerosis. Med Hypotheses 2005; 64: 925-9.
118. Rosenfeld ME. An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis. Z Kardiol 2000; 89 (Suppl 7): 2-6.
119. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Relationship between aortic calcification and atherosclerotic disease in patients with abdominal aortic aneurysm. Int Angiol 2000; 19: 276-9.
120. Judkins CP, Diep H, Broughton BR, et al. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/-mice. Am J Physiol Heart Circ Physiol 2010; 298: H24-32.
121. Mason RP. Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil. Vasc Health Risk Manag 2011; 7: 405-16.
122. Anfossi G, Russo I, Doronzo G, Pomero A, Trovati M. Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm 2010; 2010: 174341.
123. Vacca M, Degirolamo C, Mariani-Costantini R, Palasciano G, Moschetta A. Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. Wiley Interdiscip Rev Syst Biol Med, 2011; 3: 562-87.
124. Mulvihill EE, Huff MW. Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can J Cardiol 2010; 26 Suppl A: 17A-21A.
125. Calderone V, Chericoni S, Martinelli C, et al. Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch Pharmacol 2004; 370: 290-8.
126. Psotová J, Chlopšíková Š, Miketová P, Hrbáš J, Šimánek V. Chemoprotective effect of plant phenolics against anthracyclineinduced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin. Phytotherapy Res 2004; 18: 516-21.
127. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007; 137: 2405-11.
128. Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled crossover study. Br J Nutr 2009; 102: 1065-74.
129. Vlachodimitropoulou E, Sharp PA, Naftalin RJ. Quercetin-iron chelates are transported via glucose transporters. Free Radic Biol Med 2011; 50: 934-44.
130. Lakhanpal P, Rai DK. Role of quercetin in cardiovascular diseases. Internet J Med Update 2008; 3: 31-49.
131. Jin YR, Han XH, Zhang YH, et al. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-Ž2 phosphorylation and cyclooxygenase-1 activity. J Cell Biochem 2008; 104: 1-14.
132. Bojić M, Debeljak Z, Tomicic M, Medic-Saric M, Tomic S. Evaluation of antiaggregatory activity of flavonoid aglycone series. Nutr J 2011; 1: 73.
133. Gui-Rong L, Wang HB, Qin GW, et al. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. Circulation 2008; 117: 2449-57.
134. Xu YC, Yeung DKY, Man RYK, Leung SWS. Kaempferol enhances endothelium-independent and dependent relaxation in the porcine coronary artery. Mol Cell Biochem 2006; 287: 61-7.
135. Jin BH, Quin LB, Chen S, et al. Apigenin protects endotheliumdependent relaxation of rat aorta against oxidative stress. Eur J Pharmacol 2009; 16: 200-5.
136. Okutan H, Ozcelik N, Yilmaz HR, Uz E. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem 2005; 38: 191-6.
137. Huang SS, Liu SM, Lin SM, et al. Antiarrhythmic effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemia/reperfusion injury in rats. Clin Biochem 2005; 38: 943-7.
138. Dambros M, de Jongh R, van Koeveringe GA, Bast A, Heijnen CG, van Kerrebroeck PE. Flavonoid galangin prevents smooth muscle fatigue of pig urinary bladder. J Pharm Pharmacol 2005; 57: 617-22.
139. Scholz EP, Zitron E, Katus HA, Karle CA. Cardiovascular ion channels as a molecular target of flavonoids. Cardiovasc Ther 2010; 28: e46-52.
140. Al-Waili NS. Natural honey lowers plasma glucose, C-reactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose. J Med Food 2004; 7: 100-7.
141. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008; 88: 38-50.
142. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-11.
143. Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and longterm risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995; 155: 381-6.
144. Hertog MG, Sweetnam PM, Fehily AM, Elwood C, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997; 65: 1489-94.
145. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996; 312: 478-81.
146. Knekt P, Kumpulainen J, Jäarvinen R, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002; 76: 560-8.
147. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999; 49: 943-99.
148. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witterman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002; 275: 880-6.
149. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 1997; 349: 699.
150. Sesso HD, Gaziano JM, Liu S, Buring JE. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 2003; 77: 1400-8.
151. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 1996; 125: 384-9.
152. Lin J, Rexrode KM, Hu F, et al. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol 2007; 165: 1305-13.
153. Ahmad A, Khan RA, Mesaik MA. Anti-inflammatory effect of natural honey on bovine thrombin-induced oxidative burst in phagocytes. Phytother Res 2009; 23: 801-8.
154. Beretta G, Orioli M, Facino RM. Antioxidant and radical scavenging activity of honey in endothelial cell cultures (EA. hy926). Planta Med 2007; 73: 1182-9.
155. Punithavathi VR, Mainzen S, Prince P. The cardioprotective effects of a combination of quercetin and α-tocopherol on isoproterenolinduced myocardial infarcted rats. J Biochem Mol Toxicol 2011; 25: 28-40.
156. Benguedouar L, Boussenane HN, Wided K, Alyane M, Rouibah H, Lahouel M. Efficiency of propolis extract against mitochondrial stress induced by antineoplasic agents (doxorubicin and vinblastin) in rats. Indian J Exp Biol 2008; 46: 112-9.
157. Chopra S, Pillai KK, Husain SZ, Girl DK. Propolis Protects against doxorubicin-induced myocardiopathy in rats. Exp Mol Pathol 1995; 62: 190-8.
158. Alyane M, Kebsa LB, Boussenane HN, Rouibah H, Lahouel M. Cardioprotective effects and mechanism of action of polyphenols extracted from propolis against doxorubicin toxicity. Pak J Pharm Sci 2008; 21: 201-9.
159. Massignani JJ, Lemos M, Maistro EL, et al. Antiulcerogenic activity of the essential oil of Baccharis dracunculifolia on different experimental models in rats. Phytother Res 2009; 23: 1355-60.
160. Erejuwa OO, Sulaiman SA, Wahab MS, Salam SK, Salleh MS, Gurtu S. Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocininduced diabetic rats. Int J Mol Sci 2010; 11: 2056-66.
161. Li D, Liu L, Chen H, Sawamura T, Ranganathan S, Mehta JL. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 2003; 107: 612-7.
162. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707-27.
163. Du J, Brink M, Peng T, Mottironi B, Delafonataine P. Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway. Circ Res 2001; 88: 1044-52.
164. Olieslagers S, Pardali E, Tchaikovski V, Ten Dijke P, Waltenberger J. TGF-α1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus. Cardiovasc Res 2011; 91: 510-8.
165. Alexander RW. Theodore cooper memorial lecture. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 25: 155-61.
166. West XZ, Malinin NL, Merkulova AA, et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010; 467: 972-6.
167. Lo YY, Wong JM, Cruz TF. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem 1996; 271: 15703-7.
168. Watanabe Y, Suzuki O, Haruyama T, Akaike T. Interferon-gamma induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. J Cell Biochem 2003; 89: 244-53.
169. Cheng TH, Cheng PY, Shih NL, Chen IB Wang DL, Chen JJ. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 2003; 42: 1845-54.
170. Cominacini L, Garbin U, Pasini AF, et al. Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine. J Hypertens 1998; 16: 1913-9.
171. Colavitti R, Pani G, Bedogni B, et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 2002; 277: 3101-8.
172. Sundaresan M, Yu ZX, Ferrans VJ, et al. Regulation of reactiveoxygen-species generation in fibroblasts by Rac1. Biochem J 1996; 318: 379-82.
173. Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011; 10: 453-71.
174. Steinberg D. Lewis A. Conner memorial lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95: 1062-71.
175. Kaludercic N, Takimoto E, Nagayama T, et al. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res 2009; 106: 193-202.
176. Bianchi P, Kunduzova O, Masini E, et al. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 2005; 112: 3297-305.
177. Zhu W, Chen M, Shou Q, Li Y, Hu F. Biological activities of chinese propolis and brazilian propolis on streptozotocin-Induced Type 1 diabetes mellitus in rats. Evid Based Complement Alternat Med 2011: 468529.
178. Iraz M, Fadillioglu E, Tasdemir S, Erdogan S. Role of vagal activity on bradicardic and hypotensive effects of caffeic acid phenethyl ester (CAPE). Cardiovasc Toxicol 2005; 5: 391-6.
179. Yavuz H, Ozel A, Akkus I, Erkul I. Honey poisoning in Turkey. Lancet 1991; 337: 789-90.
180. Gunduz A, Turedi S, Uzun H, Topbas H. Mad honey poisoning. Am J Emerg Med 2006; 24: 595-8.
181. Onat FY, Yegen BC, Lawrence R, Oktay A, Oktay S. Site of action of grayanotoxin in mad honey in rats. J Appl Toxicol 1991; 11: 199-201.
182. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-6.
183. Catapano AL. Antioxidant effect of flavonoids. Angiology 1997; 48: 39-44.
184. García B, Castillo J. Update on uses and properties of Citrus flavonoids: New findings in anticancer, cardiovascular, and antiinflammatory activity. J Agric Food Chem 2008; 56: 6185-6205.
185. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52: 673-751.
186. Hirvonen T, Pietinen P, Virtanen M, et al. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 2001; 12: 62-7.
187. Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007; 85: 895-909.
188. Lotito SB, Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 2006; 41: 1727-46.
189. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998; 392: 559.
190. Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 2003; 78(3 Suppl): 517S-520S.
191. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 2004; 36: 838-49.
192. Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 2004; 16: 166-77.